Načítá se...
Biometals and Their Therapeutic Implications in Alzheimer’s Disease
No disease modifying therapy exists for Alzheimer’s disease (AD). The growing burden of this disease to our society necessitates continued investment in drug development. Over the last decade, multiple phase 3 clinical trials testing drugs that were designed to target established disease mechanisms...
Uloženo v:
| Vydáno v: | Neurotherapeutics |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4322070/ https://ncbi.nlm.nih.gov/pubmed/25354461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-014-0312-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|